Oric Pharmaceuticals Inc — Quarterly Dividends (NASDAQ:ORIC) | MetaTrader

Open full chart

Haberler

H.C. Wainwright, ORIC Pharmaceuticals için hedef fiyatı yükseltti

H.C. Wainwright raises ORIC Pharmaceuticals price target on trial progress

Oppenheimer ORIC hissesi için Outperform tavsiyesini tekrarladı

Oppenheimer reiterates Outperform on ORIC stock, $15 target

Oric Pharmaceuticals 200 milyon dolarlık yeni halka arz başvurusu yaptı

Oric Pharmaceuticals files new $200 million at-the-market offering prospectus

Oric Pharmaceuticals yöneticisi Heyman 80.430 dolar değerinde hisse satışı gerçekleştirdi

Oric Pharmaceuticals director Heyman sells shares worth $80,430

ORIC: Transition To Late-Stage Development Presents Upside (NASDAQ:ORIC)

Oric Pharmaceuticals Stock Sees Healthy RS Rating Jump To 80

H.C. Wainwright, ORIC Pharmaceuticals hissesi için Al tavsiyesini yineliyor

H.C. Wainwright reiterates Buy rating on ORIC Pharmaceuticals stock